Kristen O'HAlloran Cardinal

Kristen O'HAlloran Cardinal

Auto-generated profile, based on publicly available information

Kristen O'HAlloran Cardinal

Cal Poly

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
MGMichael C. Gibbons
Michael C. Gibbons
MFMarcus A. Foley
Marcus A. Foley
KCKristen O'HAlloran Cardinal
Kristen O'HAlloran Cardinal
Tissue engineers have made great strides toward the creation of living tissue replacements for a wide range of tissue types and applications, with eventual patient implantation as the primary goal. However, an alternate use of tissue-engineered constructs exists: as in vitro preclinical models for purposes such as drug screening and device testing. Tissue-engineered preclinical models have numerous potential advantages over existing models, including cultivation in three-dimensional geometries, decreased cost, increased reproducibility, precise control over cultivation conditions, and the incorporation of human cells. Over the past decade, a number of researchers have developed and used tissue-engineered constructs as preclinical models for testing pharmaceuticals, gene therapies, stents, and other technologies, with examples including blood vessels, skeletal muscle, bone, cartilage, skin, cardiac muscle, liver, cornea, reproductive tissues, adipose, small intestine, neural tissue, and kidney. The focus of this article is to review accomplishments toward the creation and use of tissue-engineered preclinical models of each of these different tissue types.

1 December 2020 in Tissue Engineering Part C: Methods
Verified
Journal Article
Open access
RMRyan Murphy
Ryan Murphy
ATAshley Turcott
Ashley Turcott
LBLeo Banuelos
Leo Banuelos
EDEvan Dowey
Evan Dowey
BGBenjamin Goodwin
Benjamin Goodwin
KCKristen O'HAlloran Cardinal
Kristen O'HAlloran Cardinal
Quantifying fiber diameter is important for characterizing electrospun polymer scaffolds. Many researchers use manual measurement methods, which can be time-consuming and variable. Semi-automated tools exist, but there is room for improvement. The current work used Matlab to develop an image analysis program to quickly and consistently measure fiber diameter in scanning electron micrographs. The new Matlab method, termed “SIMPoly” (Semiautomated Image Measurements of Polymers) was validated by using synthetic images with known fiber size and was found to be accurate. The Matlab method was also applied by three different researchers to scanning electron microscopy (SEM) images of electrospun poly(lactic-co-glycolic acid) (PLGA). Results were compared with the semi-automated DiameterJ method and a manual ImageJ measurement approach, and it was found that the Matlab-based SIMPoly method provided measurements in the expected range and with the least variability between researchers. In conclusion, this work provides and describes SIMPoly, a Matlab-based image analysis method that can simply and accurately measure polymer fiber diameters in SEM images with minimal variation between users.

13 July 2009 in Journal of Biophotonics
Verified
Journal Article
Open access
PDF file
GBGarret T. Bonnema
Garret T. Bonnema
KCKristen O. Cardinal
Kristen O. Cardinal
SWStuart K. Williams
Stuart K. Williams
JBJennifer K. Barton
Jennifer K. Barton
We have developed a 2.1 mm outer diameter optical coherence tomography endoscope that provides radial scans of luminal structures. The endoscope consists of three elements: (1) a stationary central core containing the fibers and focusing elements, (2) a rotating intermediate tube with a distal rod prism, and (3) a stationary sterilized glass cover. This design enables radial and spiral scanning and allows adjustment of the axial focal distance. Additionally, this design is capable of focusing light from multiple fibers into tissue. The performance of the endoscope was demonstrated in a study of tissue engineered blood vessels imaged at various time points during development.

26 October 2020 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Open access
PDF file
AMAlyssa McCulloch
Alyssa McCulloch
ATAshley Turcott
Ashley Turcott
GGGabriella Graham
Gabriella Graham
SFSergey Frenklakh
Sergey Frenklakh
KCKristen O'HAlloran Cardinal
Kristen O'HAlloran Cardinal
Objective The goal of this work was to endothelialize silicone aneurysm tubes for use as in vitro models for evaluating endothelial cell interactions with neurovascular devices. The first objective was to establish consistent and confluent endothelial cell linings and to evaluate the silicone vessels over time. The second objective was to use these silicone vessels for flow diverter implantation and assessment. Methods Silicone aneurysm tubes were coated with fibronectin and placed into individual bioreactor systems. Human umbilical vein endothelial cells were deposited within tubes to create silicone vessels, then cultivated on a peristaltic pump and harvested at 2, 5, 7, or 10 days to evaluate the endothelial cell lining. A subset of silicone aneurysm vessels was used for flow diverter implantation, and evaluated for cell coverage over device struts at 3 or 7 days after deployment. Results Silicone vessels maintained confluent, PECAM-1 (platelet endothelial cell adhesion molecule 1) positive endothelial cell linings over time. These vessels facilitated and withstood flow diverter implantation, with robust cell linings disclosed after device deployment. Additionally, the endothelial cells responded to implanted devices through coverage of the flow diverter struts with increased cell coverage over the aneurysm seen at 7 days after deployment as compared with 3 days. Conclusions Silicone aneurysm models can be endothelialized and successfully maintained in vitro over time. Furthermore, these silicone vessels can be used for flow diverter implantation and assessment.

27 March 2019 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
TSTiffany W. Shen
Tiffany W. Shen
BPBrandon Puccini
Brandon Puccini
KTKristen Temnyk
Kristen Temnyk
SHScott Herting
Scott Herting
KCKristen O’hAlloran Cardinal
Kristen O’hAlloran Cardinal

1 September 2016 in Applied In Vitro Toxicology
Verified
Journal Article
Closed access
SHScott Herting
Scott Herting
ADAlex DiBartolomeo
Alex DiBartolomeo
TPToni Pipes
Toni Pipes
SKShelby Kunz
Shelby Kunz
KTKristen Temnyk
Kristen Temnyk
KCKristen O'HAlloran Cardinal
Kristen O'HAlloran Cardinal
Along with the advancement of tissue engineering methods to produce implantable constructs has come the development of methods to create tissue-engineered constructs for in vitro preclinical testing of drugs, devices, and other therapeutics. Blood vessel mimics (BVMs) are examples of tissue-engineered in vitro models that have been created for the assessment of endothelial cell responses to implanted devices and intravascular imaging modalities. These BVMs could also serve as preclinical models for early-stage pharmaceutical screening. The current work aimed to build on previous BVM capabilities in three ways: by establishing and documenting a method to create dual-layer BVMs with smooth muscle and endothelial cells, by utilizing and comparing human umbilical and human coronary sources of cells, and by evaluating the ability of BVMs created with the new methods to withstand device implantation. In both umbilical and coronary BVMs, histology and scanning electron microscopy (SEM) confirmed the presence of a confluent cell layer within the lumen of the scaffold. After device deployment, SEM revealed that the cellular lining remained intact, and in umbilical vessels, some evidence of an early endothelial response was observed. The data presented here support the use of the documented methods to create dual-layer BVMs from a variety of cell sources.